Combinatorial synthesis of CCR5 antagonists.

被引：0
|
作者：
Willoughby, CA
Berk, SC
Rosauer, K
Degrado, S
Chapman, K
Springer, MS
DeMartino, JA
Gould, SL
Siciliano, SC
Malkowitz, L
Schleif, WA
Hazuda, D
Miller, M
Kessler, R
Danzisen, R
Holmes, K
Lineberger, J
Carella, A
Carver, G
Emini, E
机构：
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Immunol Res, Rahway, NJ 07065 USA
[3] Merck Res Labs, Dept Antiviral Res, Rahway, NJ 07065 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2001年 / 221卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
204-ORGN
引用
收藏
页码：U138 / U138
页数：1
相关论文
共 50 条
  • [1] Combinatorial synthesis of CCR5 antagonists
    Willoughby, CA
    Berk, SC
    Rosauer, KG
    Degrado, S
    Chapman, KT
    Gould, SL
    Springer, MS
    Malkowitz, L
    Schleif, WA
    Hazuda, D
    Miller, M
    Kessler, J
    Danzeisen, R
    Holmes, K
    Lineberger, J
    Carella, A
    Carver, G
    Emini, EA
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (24) : 3137 - 3141
  • [2] Secondary effects of treatment with maraviroc and other CCR5 antagonists. Potential impact of the CCR5 blocker
    Arribas Lopez, Jose R.
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2008, 26 : 23 - 27
  • [3] Spiropiperidine CCR5 antagonists
    Rotstein, David M.
    Gabriel, Stephen D.
    Makra, Ferenc
    Filonova, Lubov
    Gleason, Shelley
    Brotherton-Pleiss, Christine
    Setti, Lina Q.
    Trejo-Martin, Alejandra
    Lee, Eun Kyung
    Sankuratri, Surya
    Ji, Changhua
    deRosier, Andre
    Dioszegi, Marianna
    Heilek, Gabrielle
    Jekle, Andreas
    Berry, Pamela
    Weller, Paul
    Mau, Cheng-I
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (18) : 5401 - 5406
  • [4] Resistance to CCR5 antagonists
    Westby, Mike
    [J]. CURRENT OPINION IN HIV AND AIDS, 2007, 2 (02) : 137 - 144
  • [5] Recent advances of CCR5 antagonists
    Baba, Masanori
    [J]. CURRENT OPINION IN HIV AND AIDS, 2006, 1 (05) : 367 - 372
  • [6] Serious doubts on safety and efficacy of CCR5 antagonists CCR5 antagonists teeter on a knife-edge
    Horster, S.
    Goebel, F. D.
    [J]. INFECTION, 2006, 34 (02) : 110 - 113
  • [7] CCR5 antagonists: a new class of antiretrovirals
    de la Tribonniere, X.
    Yazdanpanah, Y.
    Reynes, J.
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 2008, 38 : S1 - S6
  • [8] Orally bioavailable competitive CCR5 antagonists
    Thoma, G
    Nuninger, F
    Schaefer, M
    Akyel, KG
    Albert, R
    Beerli, C
    Bruns, C
    Francotte, E
    Luyten, M
    MacKenzie, D
    Oberer, L
    Streiff, MB
    Wagner, T
    Walter, H
    Weckbecker, G
    Zerwes, HG
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (08) : 1939 - 1955
  • [9] Future of maraviroc and other CCR5 antagonists
    Overton, E. Turner
    Powderly, William G.
    [J]. FUTURE VIROLOGY, 2006, 1 (05) : 605 - 613
  • [10] CCR5 antagonists: the answer to inflammatory disease?
    Ness, Traci L.
    Kunkel, Steven L.
    Hogaboam, Cory M.
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (08) : 1051 - 1065
12345